These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25373811)

  • 1. Pregabalin for the management of cervicogenic headache: a double blind study.
    Boudreau GP; Marchand L
    Can J Neurol Sci; 2014 Sep; 41(5):603-10. PubMed ID: 25373811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Cervicogenic Headache: New Insights on the Treatment of Pain in the Neck.
    Chitsantikul P; Becker WJ
    Can J Neurol Sci; 2015 Nov; 42(6):357-9. PubMed ID: 26866063
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
    Simpson DM; Rice AS; Emir B; Landen J; Semel D; Chew ML; Sporn J
    Pain; 2014 Oct; 155(10):1943-54. PubMed ID: 24907403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study.
    Ashina H; Iljazi A; Al-Khazali HM; Eigenbrodt AK; Larsen EL; Andersen AM; Hansen KJ; Bräuner KB; Mørch-Jessen T; Chaudhry B; Antic S; Christensen CE; Ashina M; Amin FM; Schytz HW
    J Headache Pain; 2020 Jun; 21(1):62. PubMed ID: 32493206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occipital nerve blockade for cervicogenic headache: a double-blind randomized controlled clinical trial.
    Naja ZM; El-Rajab M; Al-Tannir MA; Ziade FM; Tawfik OM
    Pain Pract; 2006 Jun; 6(2):89-95. PubMed ID: 17309715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.
    Arnold LM; Arsenault P; Huffman C; Patrick JL; Messig M; Chew ML; Sanin L; Scavone JM; Pauer L; Clair AG
    Curr Med Res Opin; 2014 Oct; 30(10):2069-83. PubMed ID: 24867298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of pregabalin for treating subjects with fibromyalgia and moderate or severe baseline widespread pain.
    Clair A; Emir B
    Curr Med Res Opin; 2016; 32(3):601-9. PubMed ID: 26694975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial.
    Markman J; Resnick M; Greenberg S; Katz N; Yang R; Scavone J; Whalen E; Gregorian G; Parsons B; Knapp L
    J Neurol; 2018 Dec; 265(12):2815-2824. PubMed ID: 30242745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial.
    Huffman CL; Goldenberg JN; Weintraub J; Sanin L; Driscoll J; Yang R; Chew ML; Scavone JM
    Clin J Pain; 2017 Jul; 33(7):569-578. PubMed ID: 27753650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a Single-Dose of Pre-Emptive Pregabalin on Postoperative Pain and Opioid Consumption After Double-Jaw Surgery: A Randomized Controlled Trial.
    Ahiskalioglu A; İnce İ; Aksoy M; Yalcin E; Ahiskalioglu EO; Kilinc A
    J Oral Maxillofac Surg; 2016 Jan; 74(1):53.e1-7. PubMed ID: 26433040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
    French J; Brandt C; Friedman D; Biton V; Knapp L; Pitman V; Chew M; Dubrava S; Posner HB
    Epilepsia; 2014 Aug; 55(8):1220-8. PubMed ID: 24962242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.